Armodafinil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06413 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 13 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | faciodigitogenital syndrome | KG + DL |
| 3 | Wernicke-Korsakoff syndrome | KG + DL |
| 4 | disorder of peroxisomal alpha-, beta- and omega-oxidation | KG + DL |
| 5 | attention deficit-hyperactivity disorder | KG + DL |
| 6 | ACBD5 deficiency | KG + DL |
| 7 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 8 | narcolepsy, susceptibility to | KG + DL |
| 9 | Creutzfeldt-Jakob disease | KG + DL |
| 10 | megaconial type congenital muscular dystrophy | KG + DL |
| 11 | hypersomnia (disease) | KG + DL |
| 12 | circadian rhythm sleep disorder | KG + DL |
| 13 | cerebrospinal fluid rhinorrhea | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.